Ahead of the

<Anchor>

vaccination, a government recommendation has been issued that the elderly 65 years of age or older should carefully decide on the AstraZeneca vaccination.

Some interpretations have shown that this is a hold on vaccination for senior citizens, but the conclusion we have confirmed is that all ages can be correct.



Next, reporter Nam Joo-hyun.



<Reporter> The



conclusion of the Central Pharmacy Review Committee of the Ministry of Food and Drug Safety is that the vaccination can be administered to all ages 18 years of age or older, except for pregnant women.



However, there is a condition that the results of the clinical trial currently in progress must be submitted.



What is different from the conclusion of the previous verification advisory group is that it is recommended to put the content in the precautions for use,'Since there is not enough data on the effectiveness of vaccination over the age of 65, it should be decided carefully.'



[Il-Hwan Oh/Chairman of the Ministry of Food and Drug Safety's Central Pharmacist Review Committee: It can be thought that it opened a way for the elderly to use it.

If additional clinical trial data come out later, the prerequisites will be removed and used



. I did.



The Ministry of Food and Drug Safety explained that it meant that the vaccination committee had to establish specific guidelines for vaccination.



It is important to have AstraZeneca vaccine for people 65 years of age or older because of the high dependence of this vaccine.



Until the introduction of the Modena and Janssen vaccines after April, this vaccine is the only one other than 60,000 Pfizer vaccines.



Older people will receive this vaccine as a first target.



The Ministry of Food and Drug Safety will soon hold the final verification procedure, the final inspection committee, to decide whether to finalize the approval.